ILLUMINÉ™ Harnesses the Power of Community to Build Privacy-first, Persona-Based Media Solutions PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Health Union,…
To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the…
New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept.…
Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to…
ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased…
Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative…
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet…
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort…
Combined company will emerge as a leading global health and wellness company by providing products and solutions for families to…